NervGen Pharma Corp. (NGEN)
3.58
-0.06
(-1.65%)
USD |
NASDAQ |
May 19, 16:00
3.58
0.00 (0.00%)
After-Hours: 18:46
NervGen Pharma Cash from Investing (Quarterly) : 0.0061M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| CannaPharmaRx, Inc. | -0.0055M |
| Lexaria Bioscience Corp. | -0.0539M |
| InMed Pharmaceuticals, Inc. | 0.00 |
| Target Group, Inc. (Canada) | -0.0401M |
| Tilray Brands, Inc. | 28.63M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.978M |
| Cash from Financing (Quarterly) | 2.026M |
| Free Cash Flow | -17.09M |
| Free Cash Flow Per Share (Quarterly) | -0.0748 |
| Free Cash Flow to Equity (Quarterly) | -5.972M |
| Free Cash Flow to Firm (Quarterly) | -5.978M |
| Free Cash Flow Yield | -6.33% |